dives86 ✭

Exactly - you want to see 1) functional rejuvenation, such as immune competence 2) rejuvenation in a core ageing biomarker (e.g. epigenetic age), suggesting future persistence of that functional reju… (View Post)

@NickOttens lacking clinical trial experience myself, I would recommend reaching out to Bobby Brooke at Intervene Immune (driving the TRIIM trial, TRIIM-X trial) who has experience targeting multiple… (View Post)

I think its a good approach. As a guide, resTORbio recently pivoted their Rapalog RTB101 towards Cov19, as a prophylactic to reduce Cov19 severity in nursing home residents https://bit.ly/3im0Aoy (View Post)

Hi Nick, I think the use of a conserved or multi-species ageing biomarker, which optimises for both accuracy and translatability, would be a good idea. This would give people the flexibility to modul… (View Post)